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DURHAM, N.H. – The New Hampshire Industrial Research Center (NHIRC) at the University
of New Hampshire has provided a grant to a new company focused on developing instruments
designed to speed the analysis of proteins, which scientists believe will have a profound impact
on the drug development process.
The NHIRC has awarded Sentry BioScience Inc., with locations in Nottingham, N.H. and
Knoxville, Tenn., a grant for $49,990. Sentry is focused on developing low-cost instruments that
have the potential to accelerate the analysis of proteins, called proteomics. Proteomics is a
fledgling industry, with most companies focused on drug discovery tools. The instrumentation
market for proteomics is expected to grow from $720 million in 2001 to $1.7 billion by 2006 -an 18 percent annual growth rate.
Sentry is collaborating with Tom Laue, professor of biochemistry and molecular biology, and the
Center to Advance Molecular Interaction Science (CAMIS). “Proteomics is the next horizon for
developing new drugs. Pharmaceutical companies are keenly interested in having instruments
that will provide rapid, accurate measurements of the molecular interactions that are at the heart
of proteomics. CAMIS's expertise in developing instruments is a great match with Sentry's
expertise in producing commercially viable instruments,” Laue said.
The company’s initial focus on proteomics takes advantage of microfluidic technology,
prototypes of instruments and a detection system that has a patent pending. Sentry also is in the
process of raising $15 million from venture capitalists to commercialize integrated microfluidic
methods and instruments for biological applications, which will streamline the drug testing
process, shorten the time to receive results and reduce the cost per drug test.
“The expertise of Dr. Tom Laue and CAMIS offer a unique opportunity to further advance
proteomic research, advance instrumentation development as well as uses the expertise of the
CAMIS staff in developing analytical assays and experience with protein electrophoresis,” said
Diane Kozwich, chief science officer of Sentry BioSciences.
Formed by NanoDetection LLC and WRF, Sentry has more than seven years and $6.5 million
vested in the development of an Application Specific Integrated Circuit (ASIC) biochip
(investment comes from NanoDetection LLC).
Since 1992 the NHIRC has impacted the state's economy with $225 million in new sales and
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more than 3,170 new jobs. Created by the New Hampshire Legislature, the center provides the
means for improving the competitiveness of New Hampshire industry and the upgrading and
development of new and old products through the support and cooperation of the state with
industry and business. The supported research, innovation and technology transfer activities
preserve and increase the number of jobs in New Hampshire. For more information on the NH
Industrial Research Center, visit http://www.nhirc.unh.edu or call 603-862-0123.
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